Skip to main content
. 2022 Nov 7;14(21):5465. doi: 10.3390/cancers14215465

Table 3.

The relationship between composite ratios and cumulative scores and their component values in GEP-NEN (n = 102).

n (%) Median (Range) Median (Range)
NLR Neutrophils (×109/L) Lymphocytes (×109/L)
<3 42 (41.6%) 4.1 (2.4–6.6) 2.1 (1.3–6.2)
3–5 30 (29.7%) 4.9 (2.9–10.2) 1.4 (0.6–2.9)
>5 29 (28.7%) 8.7 (4.9–19.7) 0.9 (0.4–2.7)
NLS
0 39 (38.6%) 4.8 (2.4–7.4) 2.1 (1.5–6.2)
1 45 (44.6%) 4.9 (2.5–15.1) 1.3 (0.5–2.9)
2 17 (16.8%) 9.5 (7.9–19.7) 0.8 (0.4–1.4)
NPS Neutrophils (×109/L) Platelets (×109/L)
0 74 (73.3%) 4.5 (2.4–7.4) 250 (127–396)
1 23 (22.7%) 9.0 (4.1–19.7) 277 (137–595)
2 4 (3.9%) 9.4 (7.6–15.1) 425 (406–555)
PLR Platelets (×109/L) Lymphocytes (×109/L)
≤150 42 (41.6%) 233 (124–406) 2.1 (0.9–6.2)
>150 59 (58.4%) 267 (137–595) 1.2 (0.4–2.9)
PLS
0 40 39.6%) 267 (168–378) 2.1 (1.5–6.2)
1 60 (59.4%) 250 (127–595) 1.2 (0.4–2.9)
2 1 (0.9%) - -
CAR Albumin (g/L) CRP (mg/dL)
≤0.22 67 (65.7%) 40 (30–51) 2.0 (0.0–9.4)
>0.22 35 (34.3%) 35 (18–46) 26.5 (6.0–242.0)
GPS
0 59 57.8%) 40 (31–51) 2.0 (0.0–8.1)
1 26 (25.5%) 36 (25–46) 9.9 (0.3–98.4)
2 17 (16.7%) 31 (18–35) 40.7 (10.0–242.0)
PNI Albumin (g/L) Lymphocytes (×109/L)
≥50 34 (33.7%) 45 (31–51) 1.9 (0.8–6.2)
<50 67 (66.3%) 36 (18–44) 1.2 (0.4–2.9)
PI WBC (×109/L) CRP (mg/dL)
0 63 (61.7%) 7.0 (4.1–10.8) 2.2 (0.0–40.7)
1 27 (26.5%) 9.9 (4.8–17.8) 11.7 (0.6–186.0)
2 12 (11.7%) 12.5 (10.1–22.3) 36.6 (12.6–242.0)

NLR, neutrophil–lymphocyte ratio; NLS, neutrophil–lymphocyte score; NPS, neutrophil–platelet-score; PLR, platelet–lymphocyte ratio; PLS, platelet–lymphocyte score; CAR C, reactive protein albumin ratio; CRP, C-reactive protein; GPS, Glasgow Prognostic Score; PI, prognostic index; PNI, prognostic nutritional index; WBC, white blood cell count.